Across the recent three months, 14 analysts have shared their insights on Couchbase BASE, expressing a variety of opinions spanning from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 3 | 8 | 3 | 0 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 3 | 5 | 2 | 0 | 0 |
| 2M Ago | 0 | 1 | 0 | 0 | 0 |
| 3M Ago | 0 | 2 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Couchbase, presenting an average target of $31.71, a high estimate of $37.00, and a low estimate of $23.00. Observing a 20.52% increase, the current average has risen from the previous average price target of $26.31.
Diving into Analyst Ratings: An In-Depth Exploration
In examining recent analyst actions, we gain insights into how financial experts perceive Couchbase. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Kash Rangan | Goldman Sachs | Raises | Neutral | $30.00 | $20.00 |
| Rudy Kessinger | DA Davidson | Raises | Buy | $35.00 | $27.00 |
| Brad Reback | Stifel | Raises | Buy | $33.00 | $24.00 |
| Matthew Hedberg | RBC Capital | Raises | Outperform | $35.00 | $32.00 |
| Ittai Kidron | Oppenheimer | Raises | Outperform | $36.00 | $25.00 |
| Rob Oliver | Baird | Raises | Outperform | $35.00 | $28.00 |
| Raimo Lenschow | Barclays | Raises | Equal-Weight | $33.00 | $29.00 |
| Howard Ma | Guggenheim | Raises | Buy | $32.00 | $27.00 |
| Andrew Nowinski | Wells Fargo | Raises | Overweight | $37.00 | $34.00 |
| Andrew Nowinski | Wells Fargo | Raises | Overweight | $34.00 | $26.00 |
| Raimo Lenschow | Barclays | Raises | Equal-Weight | $29.00 | $26.00 |
| Raimo Lenschow | Barclays | Raises | Overweight | $26.00 | $23.00 |
| Matthew Hedberg | RBC Capital | Maintains | Outperform | $26.00 | - |
| Raimo Lenschow | Barclays | Raises | Overweight | $23.00 | $21.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Couchbase. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Couchbase compared to the broader market.
- Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Couchbase's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Couchbase's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Couchbase analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
All You Need to Know About Couchbase
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a highly scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud.
Couchbase: Financial Performance Dissected
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Couchbase's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 18.82% as of 31 October, 2023, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Couchbase's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -35.48%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Couchbase's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -12.0%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Couchbase's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -6.83%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: Couchbase's debt-to-equity ratio is below the industry average at 0.04, reflecting a lower dependency on debt financing and a more conservative financial approach.
Understanding the Relevance of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
